Keywords: alkermes, alcoholism, drug, gets, fda, priority, review

Alkermes' alcoholism drug gets FDA priority review

Article | 06 June 2005

Print This

Alkermes says that its New Drug Application for Vivitrex (naltrexone long-acting injection) has been accepted for a priority review by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in